Back to search
FDAFDA · Food and drugs·Recall number D-0770-2023

Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28

Published May 31, 2023 · Recall initiated: April 27, 2023

Summary

FDA records drug Class III recall D-0770-2023, published May 31, 2023 and initiated April 27, 2023. Recalling firm: Teva Pharmaceuticals USA Inc; Status: Terminated; Reported quantity: 3032; Lot: Lot#: 42617832, Exp 06/2023; 42619530, Exp 08/2023; 100020532, Exp 11/2024. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Incorrect or Missing Package Insert

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Teva Pharmaceuticals USA Inc
Distributor
US Nationwide
Lot
Lot#: 42617832, Exp 06/2023; 42619530, Exp 08/2023; 100020532, Exp 11/2024
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fentanyl Buccal Tablets CII, 800mcg, packaged in cartons of 28 Buccal Tablets (4 tablets x 7 cards), Rx only, Distributed by: Mayne Pharma, Greenville, NC 27834, NDC 51862-638-28 recalled?

Yes. FDA published recall D-0770-2023 on May 31, 2023. Reported hazard: Labeling: Incorrect or Missing Package Insert

What should I do if I have this product?

Voluntary: Firm initiated · Letter